President Donald Trump has announced that all generic drugs imported into the United States would co

FBT delivered 52.4% returns over one year but with deeper drawdowns, while XLV's diversified approac

The transaction involved 40,000 shares with an estimated value of $3.5 million on the July 15, 2026

The transaction involved the sale of 10,000 shares at $88.30 per share, resulting in a total value o

The transaction realized $1.9 million in gross proceeds on July 7, 2026, at a weighted average price

Corcept Therapeutics maintains a Buy rating, supported by robust revenue growth, pipeline progress,

Crinetics Pharmaceuticals (NASDAQ:CRNX | CRNX Price Prediction) shares have climbed 99% just this we

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

NEW YORK, June 25, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is inves

CORT resubmits relacorilant NDA for Cushing's syndrome, with updated analyses and data from multiple

NEW YORK, June 17, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is i

Corcept Therapeutics Incorporated (NASDAQ:CORT), a commercial-stage company engaged in the discovery

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercia

New York, New York--(Newsfile Corp. - June 16, 2026) - Kuehn Law, PLLC, a shareholder litigation law

Compare portfolio strategies, cost structures, and risk profiles as two Invesco healthcare ETFs take

Corcept shares surge 42% in a month as relacorilant advances in Cushing's syndrome and Lifyorli appr

New data from CATALYST and MOMENTUM trials presented at American Diabetes Association's (ADA) 86

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discover

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercia

Compare risk profiles, dividend strategies, and portfolio concentration as these two healthcare ETFs

Explore how these two healthcare ETFs differ in diversification, sector focus, and portfolio concent

Compare diversification strategies and see how each ETF's unique index focus shapes risk and return

On May 19, 2026, Corcept Therapeutics Incorporated (the "Company") learned that the United S

Corcept Therapeutics Incorporated (NASDAQ:CORT), a commercial-stage company engaged in the discovery

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercia

Canaccord Genuity analyst Edward Nash maintains Corcept Therapeutics (NASDAQ:CORT) with a Buy and

Top Wall Street analysts changed outlook on top names. See all analyst rating changes, including upg

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Corcept Therapeutics (NASDAQ:COR

Corcept Therapeutics Incorporated (NASDAQ:CORT), a commercial-stage company engaged in the discovery

UBS analyst Ashwani Verma upgrades Corcept Therapeutics (NASDAQ:CORT) from Neutral to Buy and rai

Needham analyst Rick Patel maintained a Buy rating. Steven Madden shares closed at $47.27 on Friday.

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Corcept Therapeutics (NASDAQ:COR

Piper Sandler analyst David Amsellem maintains Corcept Therapeutics (NASDAQ:CORT) with a Overweig

Corcept shares rise after Phase 2 ALS data shows 87% lower death risk; earnings miss, revenue shortf

Corcept Therapeutics Incorporated (NASDAQ:CORT), a commercial-stage company engaged in the discovery

Corcept Therapeutics (NASDAQ:CORT) raises FY2026 sales outlook from $900.000 million-$1.000 billion

Corcept Therapeutics (NASDAQ:CORT) reported quarterly losses of $(0.30) per share which missed the a

U.S. stocks rose, with the Dow Jones gaining 350 points on Wednesday. AAR Corp (NYSE: AIR) saw a 10.

US stocks rise with the Dow gaining over 300 points. Chewy shares jump 14%. Sarepta Therapeutics sur

U.S. stocks advanced Wednesday as oil prices fell on Iran diplomacy reports. Arm jumped 15%, while T

Stocks slipped Thursday as Trump comments on Iran lifted oil prices, boosting energy shares while fi

U.S. stocks surged midday Thursday as strong GDP data pushed the Russell 2000 to record highs and in